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Raltegravir (MK-0518) is clinically used against viruses
resistant to other antiretroviral compounds. However, it
has been reported that Raltegravir induces integrase (IN)
resistance very soon after the administration of the drug.
Some residues in the protein seem to be preferentially tar-
geted: E92Q, N155H, and the double mutant G140S/
Q148H. It was demonstrated that most of these mutations
altered both 3'-processing and strand transfer activities of
IN. In this report, we addressed for the first time by real
time PCR the kinetics of the integrase mutants as well
their resistance towards Raltegravir. Furthermore, we char-
acterised the activities of the recombinant proteins. Our
data highly suggest that the resistance towards Raltegravir
is due to the mutation Q148H. This mutation results in a
slower replication kinetic which is compensate by the
G140S mutation. These data explain why only the double
mutant G140S/Q148H is observed in clinical trials as one
of the most prevalent profile of raltegravir resistance.
Two patients receiving raltegravir as part as their regimen
were followed. After a viral load decrease, these patients
harbored virological failure and selection of raltegravir
resistance mutations in the integrase gene (N155H for
patient 1 and G140S + Q148H for patient 2). At failure,
patients harbouring viruses with these raltegravir muta-
tions showed HIV viral load rebound corresponding to
baseline values.
Methods
The two most prevalent profiles of raltegravir mutations
were studied (N155H and G140S + Q148H). Recom-
binant viruses harbouring the mutations N155H, E92Q,
G140S/Q148H were constructed by site directed muta-
genesis. To study the influence of each mutation on the
residues G140 and Q148, viruses harbouring these muta-
tions were constructed. All these mutations were also
introduced in a plasmid encoding proteins in order to
obtain recombinant mutated IN.
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